Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effect of a Digital Storytelling Program on Fall Among Community-Dwelling Older Adults

29 août 2026 mis à jour par: Gizem Deniz Büyüksoy, Kirsehir Ahi Evran Universitesi

The Effect of a Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy Among Community-Dwelling Older Adults

This study aims to examine fall behaviors, fear of falling, and self-efficacy levels in older adults living at home through a digital storytelling program based on Pender's Health Promotion Model, and to evaluate the effect of this program on these variables. Research hypotheses:

H1.1: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the number of falls among the elderly.

H1.2: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the risk of falls among the elderly.

H1.3: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the fear of falling among the elderly.

H1.4: The Digital Storytelling Program based on Pender's Health Promotion Model affects the total score of the Falling Behaviors Scale for the Elderly (FBS) among the elderly.

The general population of the study consisted of 80 individuals aged 65 and over registered at family health centers in Avanos district of Nevşehir province. The sample of the study was calculated as 80 people in the analysis performed using the "G. Power-3.1" program with 95% power, 0.05 margin of error and 0.82 effect size. The effect of safe movement and walking program on reducing fear of falling in elderly individuals living in nursing homes. In the study, 40 people were assigned to each group using stratified randomization method.

Inclusion criteria:

Literate, Living at home, 65 years and older, Having internet access, Able to use communication tools such as computers, tablets or smartphones, Able to communicate verbally and visually, Not having physical conditions or diseases that would prevent exercise (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease-aortic stenosis, angina, severe musculoskeletal disease, knee and hip replacement in the last 6 months). (being bedridden),

Agreeing to participate in the study. Exclusion criteria:

Bedridden, Visually impaired, Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24).

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Kırşehir
      • Kırşehir, Kırşehir, Turquie (Türkiye), 40000
        • Kırsehir Ahi Evran University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte plus âgé

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • Participants must be literate,
  • Live at home,
  • 65 years of age or older,
  • Have internet access,
  • Able to use communication tools such as computers, tablets or smartphones,
  • Able to communicate verbally and visually,
  • Not have any physical condition or illness that would prevent them from exercising (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease - aortic stenosis, angina, severe musculoskeletal disease, having had knee or hip replacement surgery in the last 6 months),
  • Agree to participate in the study.

Exclusion Criteria:

  • Bedridden,
  • Visually impaired,
  • Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: Groupe de contrôle
Comparateur actif: Intervention Group
'Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy'

Pre-intervention: Elderly individuals meeting the inclusion and exclusion criteria will be administered an introductory information form, the Fear of Falls Scale, and the Fall Behaviors Scale for the Elderly.

Intervention implementation: Elderly individuals in the experimental group will be shown digital stories prepared within the framework of Pender's Health Promotion Model-Based Digital Storytelling Program, focusing on Individual Characteristics and Experiences, Behavior-Specific Concepts and Effects, and Behavioral Outcomes. Post-intervention: Immediately after the six-week intervention and three months after its completion, the Fear of Falls Scale and the Fall Behaviors Scale for the Elderly will be collected through face-to-face interviews with individuals.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Fear of Falling Scale
Délai: From enrollment to the end of treatment at 12 weeks.
The "Fear of Falling Scale" is used to assess a person's fear of falling while performing daily activities and developed by Tinetti et al. (1990). The scale, consisting of 10 items, has a Cronbach's alpha coefficient of 0.71 in the original study. The Turkish version, validated and proven reliable by Erdem and Emel (2004). The scale items inquire whether individuals experience fear of falling while performing activities such as "bathing, reaching into a cupboard to get an item, walking in the garden, answering the door or phone, sitting down and standing up from a chair, dressing and undressing, getting in and out of bed, doing chores in their room, and simple shopping." For each question, individuals receive "1 point for Yes" if they experience fear of falling and "0 points for No" if they do not. An increase in the average fear of falling score indicates an increased fear of falling while performing daily life activities.
From enrollment to the end of treatment at 12 weeks.
Self-Efficacy/Competence Scale
Délai: From enrollment to the end of treatment at 12 weeks
It was developed and revised by Sherer et al. (63) in 1982. Its reliability and validity in Turkish was established by Gözüm and Aksayan (9) in 1999. The Cronbach Alpha value is 0.81, and the test-retest reliability was found to be 0.92. The scale consists of 23 items and four sub-factors (behavior initiation, behavior completion, behavior maintenance, and overcoming obstacles). A minimum score of 23 and a maximum score of 115 are obtained from the scale. A high total score indicates a high perception of self-efficacy/competence. It is a 5-point Likert-type scale. It consists of options ranging from "Does not describe me at all" (1) to "Describes me very well" (5). However, items 2, 4, 5, 6, 7, 10, 11, 12, 14, 16, 17, 18, 20, and 22 are scored in the opposite direction.
From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly
Délai: From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly: Developed by Clemson et al. (2003), this scale consists of 30 items and 10 sub-dimensions. Based on self-report, the scale aims to identify the behaviors and awareness that older adults exhibit to protect themselves from potential falls. The items in the scale inquire about activities related to home life, lighting and vision, shoe use, outdoor activities, and daily life. Each item is scored from 1 to 4 on a 4-point Likert scale. "Never" is worth 1 point, while the others are worth 2 points each for "occasionally," 3 points for "usually," and 4 points for "always." The lowest and highest possible scores for the total scale and its subscales range from 1 to 4. Higher scores indicate safe/protective behaviors related to falls, while lower scores indicate risky behaviors. The sub-dimensions of the scale are as follows: The scale consists of the following items: Cognitive Adaptation (6 items), Mobility (5 items), Avoidance (5 items), Awareness (4 items
From enrollment to the end of treatment at 12 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 avril 2026

Achèvement primaire (Réel)

30 août 2026

Achèvement de l'étude (Réel)

30 août 2026

Dates d'inscription aux études

Première soumission

22 mai 2026

Première soumission répondant aux critères de contrôle qualité

1 juin 2026

Première publication (Réel)

5 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

2 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

29 août 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2025.12.19

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Type d'informations de prise en charge du partage d'IPD

  • ANALYTIC_CODE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner